Log in
Enquire now

List of SBIR/STTR awards granted to Molecular Kinetics Inc

List of SBIR/STTR awards granted to Molecular Kinetics Inc
List of SBIR/STTR awards granted to Intellisense Systems, Inc.
List of SBIR/STTR awards granted to Nanotherapeutics, Inc.
List of SBIR/STTR awards granted to Great Lakes Neurotechnologies Inc.
Strategic partnerships in virtual currency
Films directed by Agnès Varda
where
SBIR/STTR Award Recipient
is
‌
Molecular Kinetics Inc
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
Molecular Kinetics Inc SBIR Phase I Award, January 2013

A SBIR Phase I contract was awarded to Molecular Kinetics Inc in January, 2013 for $146,609.0 USD from the National Science Foundation.

‌
Molecular Kinetics Inc
National Science Foundation
National Science Foundation
SBIR
1248366
Phase I
146,609
January 1, 2013
sbir.gov/node/683154
‌
Molecular Kinetics Inc SBIR Phase II Award,

A SBIR Phase II contract was awarded to Molecular Kinetics Inc for $904,883.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
2R44GM083486-02
Phase II
904,883
sbir.gov/content/new-technology-functional-solubilization-kinases-1
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $184,155.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43CA099053-01
Phase I
184,155
sbir.gov/content/computational-and-experimental-tool-cancer-protein-0
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $95,000.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43GM066412-01A1
Phase I
95,000
sbir.gov/content/tools-accelerate-protein-structure-determination-0
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $100,000.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43CA097629-01
Phase I
100,000
sbir.gov/content/bioinformatic-tool-cancer-protein-analysis-0
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $100,000.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43GM083486-01
Phase I
100,000
sbir.gov/content/new-technology-functional-solubilization-kinases-0
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $100,000.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43CA097568-01A1
Phase I
100,000
sbir.gov/content/cancer-drug-discovery-using-disordered-protein-targets-0
‌
Molecular Kinetics Inc SBIR Phase II Award,

A SBIR Phase II contract was awarded to Molecular Kinetics Inc for $750,567.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
2R44CA110548-02A1
Phase II
750,567
sbir.gov/content/new-cancer-protein-solubility-tool-entropic-bristle-2
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $133,509.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43CA119429-01
Phase I
133,509
sbir.gov/content/pi-fish-novel-approach-discovering-druggable-sites-cancer-proteins-0
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $99,511.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43CA110548-01A1
Phase I
99,511
sbir.gov/content/new-cancer-protein-solubility-tool-entropic-bristle-0
‌
Molecular Kinetics Inc SBIR Phase I Award,

A SBIR Phase I contract was awarded to Molecular Kinetics Inc for $100,000.0 USD from the U.S. Department of Health & Human Services.

‌
Molecular Kinetics Inc
SBIR
1R43HL083566-01A2
Phase I
100,000
sbir.gov/content/cardiovascular-drug-target-identification-disordered-protein-analysis-focus-0
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us